Synthesis, structure–activity relationship, and p210 bcr-abl protein tyrosine kinase activity of novel AG 957 analogs

G Kaur, VL Narayanan, PA Risbood…

Index: Bioorganic and Medicinal Chemistry, , vol. 13, # 5 p. 1749 - 1761

Full Text: HTML

Citation Number: 23

Abstract

... Please enable JavaScript to use all the features on this page. Bioorganic & Medicinal Chemistry. Volume 13, Issue 5, 1 March 2005, Pages 1749–1761. ... The effect of chemical structural modifications of AG 957 on in vivo disposition was therefore investigated. ...

Related Articles:

Design and synthesis of novel CCR3 antagonists

[Bioorganic and Medicinal Chemistry Letters, , vol. 13, # 20 p. 3597 - 3600]

Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)

[Journal of Medicinal Chemistry, , vol. 53, # 6 p. 2482 - 2493]

Investigation of Synthetic Routes to a Key Benzopyran Intermediate of a 5HT4 Agonist

[Organic Process Research and Development, , vol. 14, # 1 p. 92 - 98]

Design and synthesis of novel CCR3 antagonists

[Bioorganic and Medicinal Chemistry Letters, , vol. 13, # 20 p. 3597 - 3600]

More Articles...